Baird Maintains Outperform on Immutep, Lowers Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Joel Beatty maintains an Outperform rating on Immutep (NASDAQ:IMMP) but lowers the price target from $7 to $6.

June 27, 2024 | 11:09 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Baird analyst Joel Beatty maintains an Outperform rating on Immutep but lowers the price target from $7 to $6.
The Outperform rating suggests continued confidence in Immutep's performance, but the lowered price target indicates some tempered expectations. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100